Journal of the American Society of Hypertension
Volume 2, Issue 4 , Pages 294-302 , July 2008

Efficacy and safety of amlodipine/valsartan compared with amlodipine monotherapy in patients with stage 2 hypertension: a randomized, double-blind, multicenter study: the EX-EFFeCTS Study

  • Maurizio Destro, MD

      Affiliations

    • Ospedale Arnaboldi, Azienda Ospedaliera di Pavia, Broni, Italy
    • Corresponding Author InformationCorresponding author: Maurizio Destro, MD, Ospedale Arnaboldi, Azienda Ospedaliera di Pavia, via Emilia 354, Broni, Italy. Tel: 00 39 0385 52214; fax: 00 39 0385 52214.
    • ,
  • Anders Luckow, MD

      Affiliations

    • General Practice Office, Viumvej, 10, Roslev, Denmark
    • ,
  • Mercedes Samson, MD

      Affiliations

    • Associated Pharmaceutical Research, Buena Park, California, USA
    • ,
  • Albert Kandra, PhD

      Affiliations

    • Biostatistics, Novartis AG, Basel, Switzerland
    • ,
  • Patrick Brunel, MD

      Affiliations

    • Clinical Development and Medical Affairs, Novartis AG, Basel, Switzerland

Received 29 October 2007 ,Accepted 15 January 2008.

References 

  1. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365:217–223
  2. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA. 2003;289:2560–2572
  3. Qureshi AI, Suri MF, Kirmani JF, Divani AA. Prevalence and trends of prehypertension and hypertension in the United States: National Health and Nutrition Examination Surveys 1976 to 2000. Med Sci Monit. 2005;11:CR403–CR409
  4. Antikainen RL, Moltchanov VA, Chukwuma C, Kuulasmaa KA, Marques-Vidal PM, Sana S, et al. Trends in the prevalence, awareness, treatment and control of hypertension: the WHO MONICA Project. Eur J Cardiovasc Prev Rehabil. 2006;13:13–29
  5. Wolf-Maier K, Cooper RS, Kramer H, Banegas JR, Giampaoli S, Joffres MR, et al. Hypertension treatment and control in five European counties, Canada, and the United States. Hypertension. 2004;43:10–17
  6. European Society of Hypertension-European Society of Cardiology. 2007 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens. 2007;25:1105–1187
  7. Bramley TJ, Gerbino PP, Nightengale BS, Frech-Tamas F. Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations. J Manag Care Pharm. 2006;12:239–245
  8. Andreadis EA, Tsourous GI, Marakomichelakis GE, Katsanou PM, Fotia ME, Vassilopoulos CV, et al. High-dose monotherapy vs. low-dose combination therapy of calcium channel blockers and angiotensin receptor blockers in mild to moderate hypertension. J Hum Hypertens. 2005;19:491–496
  9. Kjeldsen SE, Aksnes TA, de la Sierra A, Ruilope LM. Amlodipine and valsartan: calcium channel blockers/angiotensin II receptor blockers combination for hypertension. Therapy. 2007;4:31–40
  10. Julius S, Kjeldsen SE, Weber M, Brunner HR, Ekman S, Hansson L, et al. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet. 2004;363:2022–2031
  11. Dahlöf B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet. 2005;366:895–906
  12. Mochizuki S, Dahlöf B, Shimizu M, Ikewaki K, Yoshikawa M, Taniquchi I, et al. Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart study): a randomised, open-label, blinded endpoint morbidity-mortality study. Lancet. 2007;369:1431–1439
  13. Poldermans D, Glazer R, Karagiannis S, Wernsing M, Kaczor J, Chiang YT, et al. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension. Clin Ther. 2007;29:279–289
  14. Williams B, Poulter NR, Brown MJ, Davis M, McInnes GT, Potter JF, et al. Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV. J Hum Hypertens. 2004;18:139–185
  15. Philipp T, Smith TR, Glazer R, Wernsing M, Yen J, Jin J, et al. Two multicenter, 8-week, randomized, double-blind placebo controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension. Clin Ther. 2007;29:563–580
  16. Sica DA. Fixed-dose combination antihypertensive drugs: do they have a role in rational therapy?. Drugs. 1994;48:16–24
  17. Burges RA, Gardiner DG, Carter AJ, Mckay FF. Amlodipine (Long-term natriuretic and antihypertensive activity in spontaneously hypertensive rats with developing and established hypertension). Ann NY Acad Sci. 1988;522:516–518
  18. Munger MA. Critical overview of antihypertensive therapies: what is preventing us from getting there?. Am J Manag Care. 2000;6:S211–S221
  19. A 6-week Multi-Center, Randomized, Double-Blind, Parallel Group Study Comparing the Efficacy of Amlodipine Besylate/Benazepril Versus Amlodipine in the Treatment of Severe Hypertension (Novartis data on file 2006). http://clinicaltrials.gov/ct2/show/NCT00136851

 This study was supported and funded by Novartis Pharma AG, Basel, Switzerland. Maurizio Destro has given talks at Scientific Meetings organized by Novartis. Albert Kandra and Patrick Brunel are employees of Novartis Pharma AG. EX-EFFeCTS in the title of the article stands for: EXforge EFFicacy and Control in Treatment of Stage 2 hypertension.

PII: S1933-1711(08)00012-0

doi: 10.1016/j.jash.2008.01.004

Journal of the American Society of Hypertension
Volume 2, Issue 4 , Pages 294-302 , July 2008

Article Tools

* Image Usage & Resolution